GUILIN, CHINA: A worker at Guilin Pharmaceutical, one of only two Chinese companies converting what was formerly considered wild grass herbs into raw material for treating malaria, 08 December 2004 in Guilin, in southern China’s Guangxi province. Combined with another anti-malarial drug, the sweet wormwood’s ingredients form a treatment called artemisinin-class combination therapy (ACT), which can cure patients within three days with few problems of drug resistance. The World Health Organization and other health agencies this year pushed for countries everywhere to use drugs made from sweet wormwood to treat the disease that strikes 300 million people each year, killing one million, mostly children. AFP PHOTO/Frederic J. BROWN. (Photo credit should read FREDERIC J. BROWN/AFP/Getty Images)